We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Why Veeva Systems (VEEV) Dipped More Than Broader Market Today
Read MoreHide Full Article
In the latest close session, Veeva Systems (VEEV - Free Report) was down 1.9% at $307.00. The stock fell short of the S&P 500, which registered a loss of 0.51% for the day. Meanwhile, the Dow gained 0.41%, and the Nasdaq, a tech-heavy index, lost 1.07%.
The stock of provider of cloud-based software services for the life sciences industry has risen by 14.5% in the past month, leading the Medical sector's gain of 8.21% and the S&P 500's loss of 0.87%.
The upcoming earnings release of Veeva Systems will be of great interest to investors. The company's upcoming EPS is projected at $2.33, signifying a 14.22% increase compared to the same quarter of the previous year. Meanwhile, the latest consensus estimate predicts the revenue to be $933.79 million, indicating a 15.11% increase compared to the same quarter of the previous year.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $9.22 per share and a revenue of $3.69 billion, indicating changes of +13.83% and +15.35%, respectively, from the former year.
Investors should also pay attention to any latest changes in analyst estimates for Veeva Systems. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has remained unchanged. Veeva Systems is holding a Zacks Rank of #3 (Hold) right now.
Valuation is also important, so investors should note that Veeva Systems has a Forward P/E ratio of 33.95 right now. This indicates no noticeable deviation in contrast to its industry's Forward P/E of 33.95.
We can additionally observe that VEEV currently boasts a PEG ratio of 0.97. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. As the market closed yesterday, the Medical Info Systems industry was having an average PEG ratio of 3.06.
The Medical Info Systems industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 87, which puts it in the top 36% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.
View the Zacks #1 Rank List
Image: Bigstock
Why Veeva Systems (VEEV) Dipped More Than Broader Market Today
In the latest close session, Veeva Systems (VEEV - Free Report) was down 1.9% at $307.00. The stock fell short of the S&P 500, which registered a loss of 0.51% for the day. Meanwhile, the Dow gained 0.41%, and the Nasdaq, a tech-heavy index, lost 1.07%.
The stock of provider of cloud-based software services for the life sciences industry has risen by 14.5% in the past month, leading the Medical sector's gain of 8.21% and the S&P 500's loss of 0.87%.
The upcoming earnings release of Veeva Systems will be of great interest to investors. The company's upcoming EPS is projected at $2.33, signifying a 14.22% increase compared to the same quarter of the previous year. Meanwhile, the latest consensus estimate predicts the revenue to be $933.79 million, indicating a 15.11% increase compared to the same quarter of the previous year.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $9.22 per share and a revenue of $3.69 billion, indicating changes of +13.83% and +15.35%, respectively, from the former year.
Investors should also pay attention to any latest changes in analyst estimates for Veeva Systems. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has remained unchanged. Veeva Systems is holding a Zacks Rank of #3 (Hold) right now.
Valuation is also important, so investors should note that Veeva Systems has a Forward P/E ratio of 33.95 right now. This indicates no noticeable deviation in contrast to its industry's Forward P/E of 33.95.
We can additionally observe that VEEV currently boasts a PEG ratio of 0.97. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. As the market closed yesterday, the Medical Info Systems industry was having an average PEG ratio of 3.06.
The Medical Info Systems industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 87, which puts it in the top 36% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.